Identification of priority pharmaceuticals in the water environment of China

Chemosphere

Volumn 89, Issue 3, 2012, Pages 280-286

  Sui, Qian ^a,b   Wang, Bin ^b   Zhao, Wentao ^c   Huang, Jun ^b   Yu, Gang ^b   Deng, Shubo ^b   Qiu, Zhaofu ^a   Lu, Shuguang ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b TSINGHUA UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Consumption; Ecological effect; Pharmaceutical; Priority; Ranking; Wastewater

Indexed keywords

DRUG PRODUCTS; ECOLOGY; WASTEWATER; WASTEWATER TREATMENT;

ANTI-INFLAMMATORIES; CONSUMPTION; ECOLOGICAL EFFECT; PRIORITY; RANKING; REMOVAL PERFORMANCE; WASTEWATER TREATMENT PLANTS; WATER ENVIRONMENTS;

ANTIBIOTICS;

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; CEFALEXIN; DICLOFENAC; ERYTHROMYCIN; IBUPROFEN; KETOCONAZOLE;

ANTIBIOTICS; DATA SET; DRUG; IDENTIFICATION METHOD; MONITORING; POLLUTION EFFECT; PRIORITIZATION; WASTEWATER; WATER TREATMENT;

AQUATIC ENVIRONMENT; ARTICLE; CHINA; CLINICAL CLASSIFICATION; DRUG IDENTIFICATION; DRUG USE; ENVIRONMENTAL IMPACT; SCORING SYSTEM; WASTE COMPONENT REMOVAL; WASTE WATER TREATMENT PLANT;

CHINA;

EID: 84864068439     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2012.04.037     Document Type: Article

References (36)

1. Besse J., Garric J. Human pharmaceuticals in surface waters: implementation of a prioritization methodology and application to the French situation. Toxicol. Lett. 2008, 176:104-123.
2. Besse J.P., Kausch-Barreto C., Garric J. Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: application to the French situation and preliminary prioritization. Hum. Ecol. Risk Assess. 2008, 14:665-695.
3. Chang H., Hu J.Y., Wang L.Z., Shao B. Occurrence of sulfonamide antibiotics in sewage treatment plants. Chin. Sci. Bull. 2008, 53:514-520.
4. Chang X.S., Meyer M.T., Liu X.Y., Zhao Q., Chen H., Chen J.A., Qiu Z., Yang L., Cao J., Shu W. Determination of antibiotics in sewage from hospitals, nursery and slaughter house, wastewater treatment plant and source water in chongqing region of three gorge reservoir in China. Environ. Pollut. 2010, 158:1444-1450.
5. China Medicine Economic Information Net (CMEIN), 2008. Chinese medical statistical yearbook (2006-2007). CMEIN, Beijing.
6. De Voogt P., Janex-Habibi M.L., Sacher F., Puijker L., Mons M. Development of a common priority list of pharmaceuticals relevant for the water cycle. Water Sci. Technol. 2009, 59:39-46.
7. European Commission, 1996. Technical guidance document in support of commission directive 93/67/EEC on risk assessment for new notified substances and commission regulation (EC) No. 1488/94 on risk assessment for existing substances. Office for Official Publications of the European Communities, Luxembourg, 328-334.
8. Ferrari B., Paxéus N., Giudice R.L., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Safety 2003, 55:359-370.
9. Halling-Sørensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lützhøft H.C., Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36:357-393.
10. Hirsch R., Ternes T., Haberer K., Kratz K.L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 1999, 225:109-118.
11. Howard P.H., Muir D.C.G. Identifying new persistent and bioaccumulative organics among chemicals in commerce II: Pharmaceuticals. Environ. Sci. Technol. 2011, 45:6938-6946.
12. Huber M.M., Gobel A., Joss A., Hermann N., Loffler D., Mcardell C.S., Ried A., Siegrist H., Ternes T.A., Gunten U.V. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ. Sci. Technol. 2005, 39:4290-4299.
13. Jia A., Xiao Y., Hu J.Y., Asami M., Kunikane S. Simultaneous determination of tetracyclines and their degradation products in environmental waters by liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 2009, 1216:4655-4662.
14. Jiang L., Hu X.L., Yin D.Q., Zhang H.C., Yu Z.Y. Occurrence, distribution and seasonal variation of antibiotics in the Huangpu River, Shanghai, China. Chemosphere 2011, 82:822-828.
15. Kim Y., Jung J., Kim M., Park J., Boxall A.B.A., Choi K. Prioritizing veterinary pharmaceuticals for aquatic environment in Korea. Environ. Toxicol. Pharmacol. 2008, 26:167-176.
16. Kumar A., Xagoraraki I. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system. Sci. Total Environ. 2010, 408:5972-5989.
17. Li B., Zhang T. Mass flows and removal of antibiotics in two municipal wastewater plants. Chemosphere 2011, 83:1284-1289.
18. Lin A.Y.C., Yu T.H., Lateef S.K. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan. J. Hazard. Mater. 2009, 167:1163-1169.
19. Metcalfe C.D., Miao X.S., Koenig B.G., Struger J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower great lakes. Canada Environ. Toxicol. Chem. 2003, 22:2881-2889.
20. Munoz I., Gomez M.J., Molina-Diaz A., Huijbregts M.A.J., Fernandez-Alba A.R., Garcia-Calvo E. Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment. Chemosphere 2008, 74:37-44.
21. Nakada N., Tanishima T., Shinohara H., Kiri K., Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res. 2006, 40:3297-3303.
22. Ort C., Hollender J., Schaerer M., Siegrist H. Model-based evaluation of reduction strategies for micropollutants from wastewater treatment plants in complex river networks. Environ. Sci. Technol. 2009, 43:3214-3220.
23. Perazzolo C., Morasch B., Kohn T., Magnet A., Thonney D., Chevre N. Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part I: Priority list for environmental risk assessment of pharmaceuticals. Environ. Toxicol. Chem. 2010, 29:1649-1657.
24. Pomati F., Netting A.G., Calamari D., Neilan B.A. Effects of erythromycin, tetracycline and ibuprofen on the growth of Synechocystis sp. and Lemna minor. Aquat. Toxicol. 2004, 67:387-396.
25. Radjenovic J., Petrovic M., Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43:831-841.
26. Reungoat U., Escher B.I., Macova M., Keller J. Biofiltration of wastewater treatment plant effluent: Effective removal of pharmaceuticals and personal care products and reduction of toxicity. Water Res. 2011, 45:2751-2762.
27. Sarmah A.K., Meyer M.T., Boxall A.B.A. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere 2006, 65:725-759.
28. Shao B., Chen D., Zhang J., Wu Y.N., Sun C.J. Determination of 76 pharmaceutical drugs by liquid chromatography-tandem mass spectrometry in slaughterhouse wastewater. J. Chromatogr. A 2009, 1216:8312-8318.
29. Snyder S.A., Adham S., Redding A.M., Cannon F.S., Decarolis J., Oppenheimer J., Wert E.C., Yoon Y. Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 2007, 202:156-181.
30. Sui Q., Huang J., Deng S.B., Yu G., Fan Q. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing. China. Water Res. 2010, 44:417-426.
31. Sui Q., Huang J., Deng S.B., Chen W.W., Yu G. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes. Environ. Sci. Technol. 2011, 45:3341-3348.
32. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32:3245-3260.
33. Triebskorn R., Casper H., Heyd A., Eikemper R., Köhler H.R., Schwaiger J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2004, 68:151-166.
34. Wang L., Ying G.G., Zhao J.L., Yang X.B., Chen F., Tao R., Liu S., Zhou L.J. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of North China. Sci. Total Environ. 2010, 408:3139-3147.
35. Xu W.H., Zhang G., Zou S.C., Li X.D., Liu Y.C. Determination of selected antibiotics in the Victoria Harbour and the Pearl River, South China using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Environ. Pollut. 2007, 145:672-679.
36. Xue W.C., Wu C.Y., Xiao K., Huang X., Zhou H.D., Tsuno H., Tanaka H. Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation. Water Res. 2010, 44:5999-6010.